Neutral Zensar; target of Rs 750: Motilal Oswal

Motilal Oswal recommended accumulate rating on Zensar with a target price of Rs 750 in its research report dated July 23, 2024.

Broker Research

July 26, 2024 / 13:13 IST

Neutral

Motilal Oswal's research report on Zensar

ZENT reported a strong 1QFY25, with revenue growth of 4.3% QoQ in CC (est. 1.9%) driven by sequential growth across all verticals. Deal TCV came in at USD154m (-15% QoQ/flat YoY). EBIT declined 4% QoQ/9.0% YoY to INR1,714m and EBIT margin was down 130bp at 13.3% (-130bp QoQ). Margin fell short of our estimate of 13.9%, due to higher SG&A (+110bp QoQ, one-off due to bad debt provisions) and higher cost of delivery. PAT of INR 1,579m (-8.9% QoQ) beat our estimate of INR 1,454m, led by revenue growth and higher other income.

Outlook

ZENT reported a one-off impact (110bp) of doubtful debts from a customer’s bankruptcy filing. Adjusting for this, the company reported a margin of 16.3%, in line with its mid-teens margin guidance. The management aims to maintain mid-teens EBITDA margins and reinvest above that level for growth. We expect ZENT to deliver 15.9%/16.7% EBITDA margin in FY25/FY26. This will result in an INR PAT CAGR of 6.0% over FY24-26E (partially on high FY24 base). We increase our EPS estimates by 6.2% for FY25 on the back of growth surprise in 1Q. We largely maintain our EPS estimate for FY26. Our TP of INR750 implies 23x FY26E EPS. Retain Neutral.

For all recommendations report, click here